Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Armata Pharmaceuticals, Inc. (ARMP) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Armata Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc. are of similar size ($144.1M and $136.5M). Armata Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −19.3% against −73.7%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 17 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 9 and Armata Pharmaceuticals, Inc. on 8.

Valuation

Metric ARMP CRBP Biotechnology median
P/E n/m n/m 7.88
P/S 24.46 89.99 11.47
P/B n/m 1.36 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 71.29 22.77 10.73
Earnings yield (143.90%) (86.69%) (28.84%)
Free cash flow yield (19.02%) (62.56%) (23.03%)

Profitability

Metric ARMP CRBP Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% (95.58%) (57.72%)
Return on assets (225.11%) (80.85%) (49.22%)
Return on invested capital (89.61%) 0.00% 0.00%

Growth

Metric ARMP CRBP Biotechnology median
Revenue growth (TTM) (19.29%) (73.69%) 5.64%
EPS growth (last fiscal year) (1,398.60%) (60.33%) —
Revenue growth, 5-year CAGR 42.90% (14.34%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP CRBP Biotechnology median
Debt to equity (1.23) 0.00 0.00
Current ratio 0.11 5.71 4.73
Net debt to EBITDA (7.07) 1.90 0.96

Dividend

Metric ARMP CRBP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARMP CRBP Biotechnology median
Market cap 136.46m 144.09m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack